Literature DB >> 24947576

Shaping and managing the course of a child's disease: parental experiences with osteogenesis imperfecta.

Maman Joyce Dogba1, Frank Rauch2, Ghislaine Tre3, Francis H Glorieux2, Christophe Bedos4.   

Abstract

BACKGROUND: Osteogenesis imperfecta (OI), a rare genetic disease, causes increased bone fragility. The course of childhood chronic conditions particularly rare genetic diseases can be modified by both child and parents. However with limited research, shaping and managing that process is not well understood.
OBJECTIVE: Here we examine how parents of children with severe and mild OI have shaped and managed the condition of their child over time. Our goal is to provide a in-depth understanding of parental responses to OI.
METHODS: This study was carried out in a pediatric orthopedic hospital located in Montreal, Canada. Using the principles of interpretative description, we conducted semi-structured interviews with 48 parents of children diagnosed with OI.
RESULTS: We found that parental responses to their child' disease are constituted by their feelings and their actions. These responses changed over time. We can report four successive phases: an initial reaction, acceptance, normalization and passing the baton. Each stage affected subsequent stages. Every stage was influenced by the severity of OI, parents' individual characteristics, their day-to-day experiences and the entourage.
CONCLUSION: Our study contributes to increased understanding of parental responses to OI and to improved parental responses and ultimately the child's coping.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Children; Genetics; Illness and rare disease; North America; Osteogenesis imperfecta; Parental responses; Psychosocial issues; Qualitative; Research

Mesh:

Year:  2014        PMID: 24947576     DOI: 10.1016/j.dhjo.2014.03.002

Source DB:  PubMed          Journal:  Disabil Health J        ISSN: 1876-7583            Impact factor:   2.554


  9 in total

1.  Predicting ambulatory function at skeletal maturity in children with moderate to severe osteogenesis imperfecta.

Authors:  Kathleen Montpetit; Marie-Elaine Lafrance; Francis H Glorieux; François Fassier; Reggie Hamdy; Frank Rauch
Journal:  Eur J Pediatr       Date:  2020-07-28       Impact factor: 3.183

2.  Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle.

Authors:  Argerie Tsimicalis; Madalina Boitor; Catherine E Ferland; Frank Rauch; Sylvie Le May; Jaimie Isabel Carrier; Tracy Ngheim; Claudette Bilodeau
Journal:  Eur J Pediatr       Date:  2018-04-11       Impact factor: 3.183

3.  Quality of life in caregivers of children and adolescents with Osteogenesis Imperfecta.

Authors:  Ana Paula Vanz; Têmis M Félix; Neusa Sica da Rocha; Ida V D Schwartz
Journal:  Health Qual Life Outcomes       Date:  2015-04-01       Impact factor: 3.186

4.  From pediatric to adult care: strategic evaluation of a transition program for patients with osteogenesis imperfecta.

Authors:  Maman Joyce Dogba; Frank Rauch; Trudy Wong; Joanne Ruck; Francis H Glorieux; Christophe Bedos
Journal:  BMC Health Serv Res       Date:  2014-10-31       Impact factor: 2.655

5.  Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta.

Authors:  Melissa Hill; Celine Lewis; Megan Riddington; Belinda Crowe; Catherine DeVile; Anna L David; Oliver Semler; Magnus Westgren; Cecilia Götherström; Lyn S Chitty
Journal:  Eur J Hum Genet       Date:  2019-03-27       Impact factor: 4.246

6.  Exploring the Views of Osteogenesis Imperfecta Caregivers on Internet-Based Technologies: Qualitative Descriptive Study.

Authors:  Aimee R Castro; Khadidja Chougui; Claudette Bilodeau; Argerie Tsimicalis
Journal:  J Med Internet Res       Date:  2019-12-18       Impact factor: 5.428

7.  Involving Families with Osteogenesis Imperfecta in Health Service Research: Joint Development of the OI/ECE Questionnaire.

Authors:  Maman Joyce Dogba; Noémi Dahan-Oliel; Laurie Snider; Francis H Glorieux; Michaela Durigova; Telma Palomo; Michel Cordey; Marie-Hélène Bédard; Christophe Bedos; Frank Rauch
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

Review 8.  Managing the patient with osteogenesis imperfecta: a multidisciplinary approach.

Authors:  Caroline Marr; Alison Seasman; Nick Bishop
Journal:  J Multidiscip Healthc       Date:  2017-04-04

9.  Perceived burden in dealing with different rare diseases: a qualitative focus group study.

Authors:  Natalie Uhlenbusch; Bernd Löwe; Miriam K Depping
Journal:  BMJ Open       Date:  2019-12-29       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.